Lung ultrasound and short-term prognosis in heart failure patients.

Abstract:

BACKGROUND:Heart failure (HF) is the leading cause of hospitalization for patients older than 65years, with a 30-day readmission rate of 20-25%. Although several markers have been evaluated to stratify timing of follow-up after an acute decompensation is mostly based on clinical judgment. Lung ultrasound (LUS) has been demonstrated to be a valid tool for the assessment and monitoring of pulmonary congestion. Aim of our study was to evaluate if LUS performed in HF patients at discharge could predict 100-day hospital readmission or death. METHODS:One-hundred fifty patients were enrolled. The anterolateral chest was scanned to evaluate the presence of B-lines. A sonographic score was calculated attributing 1 to each positive (≥3 B-lines) sector. Clinical, biochemical and echocardiographic data were recorded. A Cox proportional hazard regression analysis was performed to evaluate the association between variables and 100-day events. RESULTS:Follow-up was obtained in 149 patients. Thirty-four events were recorded. Sonographic score was significantly associated with events (HR 1.19; CI 1.05 to 1.34; p=0.005). On average, the increase of 1 point in the sonographic score was associated with an increase of approximately 24% in the risk of event within 100days. At multivariate analysis NTproBNP remained the only independent prognostic factor. CONCLUSIONS:We confirmed that B-lines at discharge are a prognostic marker for hospital readmission and death at 100days in HF patients. Nevertheless, further randomized clinical studies are needed to definitely support the routine use of LUS in the clinical management of HF patients, in combination or not with NT-proBNP.

journal_name

Int J Cardiol

authors

Cogliati C,Casazza G,Ceriani E,Torzillo D,Furlotti S,Bossi I,Vago T,Costantino G,Montano N

doi

10.1016/j.ijcard.2016.05.010

subject

Has Abstract

pub_date

2016-09-01 00:00:00

pages

104-108

eissn

0167-5273

issn

1874-1754

pii

S0167-5273(16)30912-3

journal_volume

218

pub_type

杂志文章
  • The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry.

    abstract:BACKGROUND:The number and age demographic of the future Fontan population is unknown. METHODS:Population projections were calculated probabilistically using microsimulation. Mortality hazard rates for each Fontan recipient were calculated from survivorship of 1353 Fontan recipients in the Australia and New Zealand Fon...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2016.05.035

    authors: Schilling C,Dalziel K,Nunn R,Du Plessis K,Shi WY,Celermajer D,Winlaw D,Weintraub RG,Grigg LE,Radford DJ,Bullock A,Gentles TL,Wheaton GR,Hornung T,Justo RN,d'Udekem Y

    更新日期:2016-09-15 00:00:00

  • Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine.

    abstract::Levosimendan and dobutamine are comparable inotropic drugs as regards their hemodynamic effects and clinical outcomes in decompensated heart failure (HF). The aim of this study was to compare the effects of levosimendan and dobutamine treatment on NT-proBNP levels in patients with decompensated HF. Forty-four patients...

    journal_title:International journal of cardiology

    pub_type: 信件

    doi:10.1016/j.ijcard.2007.06.136

    authors: Cavusoglu Y,Tek M,Birdane A,Ata N,Demirustu C,Gorenek B,Unalir A,Timuralp B

    更新日期:2008-07-21 00:00:00

  • Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease.

    abstract::Pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) due to systemic to pulmonary shunting is associated with a high risk of morbidity and mortality. In this study we evaluated 4 years treatment effect of bosentan on exercise capacity and quality of life and survival rates in 64 adult p...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2011.06.064

    authors: Vis JC,Duffels MG,Mulder P,de Bruin-Bon RH,Bouma BJ,Berger RM,Hoendermis ES,van Dijk AP,Mulder BJ

    更新日期:2013-03-20 00:00:00

  • Clinical presentation is the main predictor of in-hospital death for patients with acute type A aortic dissection admitted for surgical treatment: a 25 years experience.

    abstract:BACKGROUND:This retrospective analysis assessed the hypothesis that clinical status on admission more than other variables related to surgical or post-operative management may influence in-hospital mortality after surgical treatment of acute type A aortic dissection. METHODS:Between January 1979 and April 2004, 311 pa...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2006.03.013

    authors: Santini F,Montalbano G,Casali G,Messina A,Iafrancesco M,Luciani GB,Rossi A,Mazzucco A

    更新日期:2007-02-14 00:00:00

  • Failed thrombolysis in myocardial infarction.

    abstract::Prompt treatment with thrombolytic therapy in acute myocardial infarction has been proven to reduce infarct size and mortality. However, reperfusion fails to occur in 30-50% of patients, either due to impaired epicardial artery flow or microvascular occlusion, with these patients experiencing a higher morbidity and mo...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,评审

    doi:10.1016/s0167-5273(00)00282-5

    authors: Qasim A,Chauhan A,More RS

    更新日期:2000-08-01 00:00:00

  • Early expressed circulating long noncoding RNA CHAST is associated with cardiac contractile function in patients with acute myocardial infarction.

    abstract:BACKGROUND:The mortality rate during the acute myocardial infarction (AMI) phase has substantially decreased, but post-AMI cardiac remodeling remains an important factor affecting patient prognosis. Several circulating long noncoding RNAs (lncRNAs) are reportedly involved in the chronic pathological process of cardiac ...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2019.12.058

    authors: Wang X,Wang L,Ma Z,Liang W,Li J,Li Y,Gui Y,Ai S

    更新日期:2020-03-01 00:00:00

  • The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism.

    abstract::Cardiometabolic risk factors affect more than 47 million adults in the United States today. Although certain risk factors (e.g., obesity, dyslipidemia, hypertension, and hyperglycemia) contribute independently to the global risk, dyslipidemia is one of the most important risk factors for cardiovascular disease. Succes...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijcard.2008.06.033

    authors: Deedwania P

    更新日期:2009-01-24 00:00:00

  • Respiratory muscle dysfunction in congestive heart failure--the role of pulmonary hypertension.

    abstract:BACKGROUND:Inspiratory muscle weakness has been described in patients with congestive heart failure (CHF), and only recently in patients with idiopathic pulmonary arterial hypertension. However, the relationship between pulmonary hemodynamics and respiratory muscle function has not been investigated in patients with CH...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.ijcard.2010.04.006

    authors: Filusch A,Ewert R,Altesellmeier M,Zugck C,Hetzer R,Borst MM,Katus HA,Meyer FJ

    更新日期:2011-07-15 00:00:00

  • Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina.

    abstract:BACKGROUND:Platelet aggregation, blood coagulation, and fibrinolysis play a pivotal role in the pathogenesis of unstable angina. METHODS:Platelet aggregability was examined on admission and after 2 weeks of treatment in 22 patients with unstable angina, in particular with regard to small-sized platelet aggregates, pla...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/s0167-5273(01)00515-0

    authors: Miyamoto S,Ogawa H,Sakamoto T,Soejima H,Takazoe K,Shimomura H,Kajiwara I,Yoshimura M,Kugiyama K,Nakamura S,Ozaki Y

    更新日期:2001-09-01 00:00:00

  • Impact of point-of-care pre-procedure creatinine and eGFR testing in patients with ST segment elevation myocardial infarction undergoing primary PCI: The pilot STATCREAT study.

    abstract:BACKGROUND:Contrast-induced acute kidney injury (CI-AKI) is a recognised complication during primary PCI that affects short and long term prognosis. The aim of this study was to assess the impact of point-of-care (POC) pre-PPCI creatinine and eGFR testing in STEMI patients. METHODS:160 STEMI patients (STATCREAT group)...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2017.03.147

    authors: Karamasis GV,Hampton-Till J,Al-Janabi F,Mohdnazri S,Parker M,Ioannou A,Jagathesan R,Kabir A,Sayer JW,Robinson NM,Aggarwal RK,Clesham GJ,Gamma RA,Kelly PA,Tang KH,Davies JR,Keeble T

    更新日期:2017-08-01 00:00:00

  • Patterns of cardiac dysfunction coinciding with exertional breathlessness in hypertrophic cardiomyopathy.

    abstract:OBJECTIVE:The commonest cause of breathlessness in hypertrophic cardiomyopathy (HCM) is left ventricular outflow tract (LVOT) obstruction which improves with its removal. However, in the absence of outflow tract obstruction, as in dilated cardiomyopathy, patients may be limited by similar symptoms, thus suggesting a po...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2013.10.059

    authors: Maras D,Chung R,Duncan A,Li W,Thorp C,Mörner S,Lindqvist P,Henein MY

    更新日期:2013-12-10 00:00:00

  • The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program.

    abstract:BACKGROUND:Sodium glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP1-RA) reduce cardiovascular events, and improve intermediate markers of cardiometabolic health, in those with type 2 diabetes. We investigated these effects in the CANVAS Program. METHODS AND RESULTS:The CAN...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2020.06.011

    authors: Arnott C,Neuen BL,Heerspink HJL,Figtree GA,Kosiborod M,Lam CS,Cannon CP,Rosenthal N,Shaw W,Mahaffey KW,Jardine MJ,Perkovic V,Neal B

    更新日期:2020-11-01 00:00:00

  • Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.

    abstract::There is some evidence that Covid 19 pneumonia is associated with prothrombotic status and increased risk of venous thromboembolic events (deep venous thrombosis and pulmonary embolism). Over a two-week period we admitted in our Unit 25 patients with Covid-19 pneumonia, of these pulmonary embolism was diagnosed using ...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2020.04.028

    authors: Faggiano P,Bonelli A,Paris S,Milesi G,Bisegna S,Bernardi N,Curnis A,Agricola E,Maroldi R

    更新日期:2020-08-15 00:00:00

  • Risk and prediction of dementia in patients with atrial fibrillation--a nationwide population-based cohort study.

    abstract:BACKGROUND:Atrial fibrillation (AF) is associated with an increased risk of cognitive impairment and functional decline, and may contribute to development of dementia. OBJECTIVES:Data from a nationwide large-scale population-based cohort study are lacking. Besides, how best to predict the occurrence of incident dement...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.ijcard.2015.06.170

    authors: Liao JN,Chao TF,Liu CJ,Wang KL,Chen SJ,Tuan TC,Lin YJ,Chang SL,Lo LW,Hu YF,Chung FP,Tsao HM,Chen TJ,Lip GY,Chen SA

    更新日期:2015-11-15 00:00:00

  • Prevention by acebutolol of rhythm disorders following coronary bypass surgery.

    abstract::Seventy-one patients submitted routinely to coronary artery bypass surgery were randomized into 2 groups. Group A (32 patients) received 24 hr after initiation of surgery an intravenous perfusion of 100 mg of acebutolol given over 24 hr (22 cases) or 600 mg administered orally (10 cases). On subsequent days, they rece...

    journal_title:International journal of cardiology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0167-5273(85)90219-0

    authors: Materne P,Larbuisson R,Collignon P,Limet R,Kulbertus H

    更新日期:1985-07-01 00:00:00

  • Pharmaco-economics of levosimendan in cardiology: a European perspective.

    abstract:INTRODUCTION:Heart failure places a significant economic burden on health care. Acute heart failure requires hospitalization and often frequent re-hospitalization in expensive wards where vasoactive rescue therapy is often added on top of standard medications. In these lean times, there is a growing need for cost-effec...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2015.07.049

    authors: Nieminen MS,Buerke M,Parissis J,Ben-Gal T,Pollesello P,Kivikko M,Karavidas A,Severino P,Comín-Colet J,Wikström G,Fedele F

    更新日期:2015-11-15 00:00:00

  • Mechanical circulatory support for life-threatening arrhythmia: A systematic review.

    abstract:BACKGROUND:The use of temporary mechanical circulatory support (tMCS) during arrhythmia is increasing, although available evidence for this indication is limited, with significant gaps of knowledge regarding appropriate timing, management and configuration. This systematic review sought to analyze the use of tMCS in pa...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2020.03.045

    authors: Mariani S,Napp LC,Lo Coco V,Delnoij TSR,Luermans JGLM,Ter Bekke RMA,Timmermans C,Li T,Dogan G,Schmitto JD,Maessen J,Maesen B,Lorusso R

    更新日期:2020-06-01 00:00:00

  • The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective.

    abstract:BACKGROUND:For patients in whom statins are not tolerated or effective as monotherapy, proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a new class of lipid lowering therapies that may reduce low-density lipoprotein cholesterol (LDL-C) levels by up to 50% and lower cardiovascular events. Whil...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2018.04.122

    authors: Kumar R,Tonkin A,Liew D,Zomer E

    更新日期:2018-09-15 00:00:00

  • Detecting of coronary dissection by coronary magnetic resonance.

    abstract::A 75-year-old man, who had a history of coronary dissection after percutaneous coronary intervention in left anterior descending coronary artery, underwent coronary magnetic resonance. Magnetic resonance demonstrated coronary dissection in the distal portion of the left anterior descending artery. Both the true lumen ...

    journal_title:International journal of cardiology

    pub_type: 信件

    doi:10.1016/j.ijcard.2007.01.026

    authors: Komatsu S,Hirayama A,Omori Y,Sasaki J,Shinohe T,Koshimune Y,Fujisawa Y,Murakawa T,Ropers D,Achenbach S,Daniel WG,Kodama K

    更新日期:2008-06-06 00:00:00

  • Cannabis as a precipitant of cardiovascular emergencies.

    abstract::Cannabis smoking is on the increase both in the United Kingdom and in the United States. For over three decades it has been known that cannabis has pathophysiological effects on the cardiovascular system, and previously an association with an increased risk of myocardial infarction has been reported. However, it is no...

    journal_title:International journal of cardiology

    pub_type: 信件

    doi:10.1016/j.ijcard.2004.10.038

    authors: Lindsay AC,Foale RA,Warren O,Henry JA

    更新日期:2005-09-30 00:00:00

  • Continuation of hormone replacement therapy during acute myocardial infarction after the women's health initiative study. Is it the time for change?

    abstract::Hormone replacement therapy (HRT) was given for many years in order to relieve menopausal symptoms and was used for as long as symptom control was necessary. The Heart and Estrogen/Progestin Replacement Study (HERS) and Women's Health Initiative (WHI) studies showed that HRT should not be given for primary or secondar...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijcard.2005.04.002

    authors: Yosefy C,Feingold M

    更新日期:2006-03-08 00:00:00

  • Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.

    abstract:BACKGROUND:In a randomized trial, baroreflex activation therapy (BAT) improved exercise capacity, quality of life and NT-proBNP in patients with heart failure with reduced ejection fraction (HFrEF). In view of different mechanisms underlying HFrEF, we performed a post-hoc subgroup analysis of efficacy and safety of BAT...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.ijcard.2018.04.075

    authors: Halbach M,Abraham WT,Butter C,Ducharme A,Klug D,Little WC,Reuter H,Schafer JE,Senni M,Swarup V,Wachter R,Weaver FA,Wilks SJ,Zile MR,Müller-Ehmsen J

    更新日期:2018-09-01 00:00:00

  • Hemodynamic factors associated with serum chloride in ambulatory patients with advanced heart failure.

    abstract:BACKGROUND:Lower serum chloride (Cl) is associated with mortality in heart failure patients and may be more prognostically relevant than sodium. However, the association of hemodynamics and Cl levels is unknown. METHODS:438 sequential patients with advanced chronic heart failure (ACHF) underwent invasive hemodynamic a...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2017.11.024

    authors: Grodin JL,Mullens W,Dupont M,Taylor DO,McKie PM,Starling RC,Testani JM,Tang WHW

    更新日期:2018-02-01 00:00:00

  • The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension.

    abstract::Pulmonary arterial hypertension is an obstructive pulmonary vasculopathy that leads to increased pulmonary vascular resistance, right ventricular overload and failure, and death. Patients' clinical status and prognosis depend mostly on the capability of the right ventricle to adapt to the increased afterload, maintain...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijcard.2019.10.043

    authors: Badagliacca R,Papa S,Matsubara H,Lang IM,Poscia R,Manzi G,Vizza CD

    更新日期:2020-02-15 00:00:00

  • Comparison of the safety between first- and second-generation drug eluting stents: meta-analysis from 19 randomized trials and 16,924 patients.

    abstract:BACKGROUND/OBJECTIVE:Despite the effectiveness of first generation drug eluting stent, DES-1 (Taxus and Cypher) in avoiding restenosis and the need for new revascularizations, a slightly increase in stent thrombosis, ST have been published. Second generation drug eluting stent, DES-2 has been developed to optimize the ...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.ijcard.2011.04.004

    authors: Martín-Reyes R,Moreno R,Sánchez-Recalde A,Navarro F,Franco J,Piñero A,Sendón JL

    更新日期:2012-10-18 00:00:00

  • Underestimation of duration of ventricular activation by 12-lead ECG compared with direct measurement of activation duration derived from implanted pacemaker leads.

    abstract:AIM:To determine extent to which 12-lead ECG QRS duration (QRSd) reflects ventricular activation duration compared with time relations from unpaced ventricular myograms in cardiac resynchronisation therapy (CRT) patients. METHODS:Left (LV) and right ventricular (RV) myograms were recorded during spontaneous rhythm fro...

    journal_title:International journal of cardiology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.ijcard.2010.07.001

    authors: Duncan AM,Lim E,Mebrate Y,Wong T,Gibson DG

    更新日期:2011-10-06 00:00:00

  • Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion.

    abstract:BACKGROUND/INTRODUCTION:Outcome after ST segment elevation myocardial infarction (STEMI), has improved but patients with high Killip class still have a poor prognosis, and those ≥II need a closer monitoring in a specialized cardiac care unit. PURPOSE:We aimed to determine the predictors of Killip class in a group of p...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2017.07.038

    authors: Vicent L,Velásquez-Rodríguez J,Valero-Masa MJ,Díez-Delhoyo F,González-Saldívar H,Bruña V,Devesa C,Juárez M,Sousa-Casasnovas I,Fernández-Avilés F,Martínez-Sellés M

    更新日期:2017-12-01 00:00:00

  • Ultrafiltration for acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials.

    abstract:BACKGROUND:Current clinical guidelines recommend ultrafiltration (UF) for patients with acute decompensated heart failure (ADHF) who are unresponsive or resistant to diuretics. We systematically reviewed the latest randomized evidence on the efficacy and safety of UF in ADHF. METHODS:MEDLINE, EMBASE and the Cochrane d...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.ijcard.2014.01.069

    authors: Kwong JS,Yu CM

    更新日期:2014-03-15 00:00:00

  • Global longitudinal speckle-tracking strain is predictive of left ventricular remodeling after coronary angioplasty in patients with recent non-ST elevation myocardial infarction.

    abstract:AIMS:To test whether two-dimensional longitudinal strain (2DSE) performed after revascularization by percutaneous coronary intervention (PCI) could predict left ventricular (LV) remodeling in patients with recent non-ST elevation myocardial infarction (NSTEMI). METHODS:In 70 patients (62.7 ± 8.7 years) with recent NST...

    journal_title:International journal of cardiology

    pub_type: 杂志文章

    doi:10.1016/j.ijcard.2010.08.025

    authors: D'Andrea A,Cocchia R,Caso P,Riegler L,Scarafile R,Salerno G,Golia E,Di Salvo G,Calabrò P,Bigazzi MC,Liccardo B,Esposito N,Cuomo S,Bossone E,Russo MG,Calabrò R

    更新日期:2011-12-01 00:00:00

  • Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection.

    abstract::During acute myocardial infarction and in the reperfused heart, loss of cardiomyocytes is mostly caused by apoptosis and necrosis. As apoptosis was considered as the only form of regulated cell death for many years, initial studies investigating cardiomyocyte cell death mainly focused on direct inhibition of apoptosis...

    journal_title:International journal of cardiology

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijcard.2012.03.055

    authors: Oerlemans MI,Koudstaal S,Chamuleau SA,de Kleijn DP,Doevendans PA,Sluijter JP

    更新日期:2013-05-25 00:00:00